Zdrowie i gospodarka · 29/06/2010
FDA Updates Regulations for Abbreviated New Drug Applications
The Food and Drug Administration (FDA) is updating its regulations to provide a single address for submitting abbreviated new drug applications (ANDAs) and related documents, aiming to improve accuracy and clarity in the agency's processes.
Source: Federal Register — Health and Human ServicesOpen original release →